jump to content jump to footer

Mint in 30 Minutes - How to adopt radiomics research, clinical trial management, and cognitive assistance in clinical routine

During this year’s virtual ECR 2020, we provided an insight into data-driven radiology with our Mint in 30 Minutes webcast. Using live software showcases, our colleagues demonstrated how to acquire structured data, how to visualize it, and how to export it by using mint Lesion™, the leading platform in radiology which leaves no data behind on the image.
 
Watch the webcast recording to discover the multitude of possibilities that mint Lesion™ can offer you: radiomics research, clinical trial management, and structured reporting in clinical routine - all in one platform.

mint Lesion usage during a clinical trial read, featuring the TGRM export tool.
Bridging the Gap Between RECIST and Survival: Why the FDA’s Analysis of the g Value is a Game-Changer
For decades, oncology trials have relied on RECIST 1.1 to evaluate drug efficacy. However, these categorical "snapshot" evaluations do not always…
Read more
Participants at the RECIST and Beyond workshop in Cologne during hands-on training with mint Lesion for structured tumor response assessment.
The two-day “RECIST and Beyond” workshop at radCIO Cologne offered intensive hands-on training on RECIST, iRECIST, mRECIST and LI-RADS, with real-case reporting performed directly in mint Lesion.
Successful “RECIST and Beyond” Workshop in Cologne: Advancing Precision in Oncologic Imaging
How can complex tumor findings be assessed accurately, reproducibly, and in line with clinical guidelines?
Read more
Screenshot of the mint Lesion interface showing RANO 2.0 configuration, tumor burden calculations, and structured neuro-oncology assessment tools.
mint Lesion fully supports RANO 2.0 implementation with configurable parameters, automated tumor burden calculations, and structured workflows for neuro-oncology clinical trials.
Implementing RANO 2.0 for Neuro-Oncology Clinical Trials in mint Lesion
Tumor response assessment in neuro-oncology clinical trials requires careful attention to measurement protocols and confirmation scan requirements. To…
Read more
scroll-top